Video: An Interview with GIBB Trial Investigator Dr. Jeff Sharman on Quality of Life and Symptoms in First-Line Obinutuzumab and Bendamustine for CLL at ASH 2017

Show All
/
leukemia
/
Lung
/
lymphoma
/
Pancreatic